EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 216 / Numéro 3-4 (2022) Biologie Aujourd’hui, 216 3-4 (2022) 105-110 Références
Accès gratuit
Numéro
Biologie Aujourd’hui
Volume 216, Numéro 3-4, 2022
Page(s) 105 - 110
DOI https://doi.org/10.1051/jbio/2022019
Publié en ligne 6 février 2023
  • Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J. (1999). Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology, 140, 5348-5355. [CrossRef] [PubMed] [Google Scholar]
  • Ben-Jonathan, N., Mershon, J.L., Allen, D.L., Steinmetz, R.W. (1996). Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects. Endocr Rev, 17, 639-669. [PubMed] [Google Scholar]
  • Bernard, V., Young, J., Chanson, P., Binart, N. (2015). New insights in prolactin: Pathological implications. Nat Rev Endocrinol, 11, 265-275. [CrossRef] [PubMed] [Google Scholar]
  • Bernard, V., Villa, C., Auguste, A., Lamothe, S., Guillou, A., Martin, A., Caburet, S., Young, J., Veitia, R.A., Binart, N. (2018a). Natural and molecular history of prolactinoma: Insights from a Prlr-/- mouse model. Oncotarget, 9, 6144-6155. [CrossRef] [PubMed] [Google Scholar]
  • Bernard, V., Lamothe, S., Beau, I., Guillou, A., Martin, A., Le Tissier, P., Grattan, D., Young, J., Binart, N. (2018b). Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo. FASEB J, 32, 4791-4797. [CrossRef] [PubMed] [Google Scholar]
  • Bernard, V., Young, J., Binart, N. (2019). Prolactin – A pleiotropic factor in health and disease. Nat Rev Endocrinol, 15, 356-365. [CrossRef] [PubMed] [Google Scholar]
  • Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., Kelly, P.A. (1998). Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev, 19, 225-268. [CrossRef] [PubMed] [Google Scholar]
  • Bouchard, P., Lagoguey, M., Brailly, S., Schaison, G. (1985). Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab, 60, 258-262. [CrossRef] [PubMed] [Google Scholar]
  • Brue, T., Delemer, B., and French Society of Endocrinology (SFE) work group on the consensus on hyperprolactinemia. (2007). Diagnosis and management of hyperprolactinemia: Expert consensus – French Society of Endocrinology. Ann Endocrinol, 68, 58-64. [CrossRef] [PubMed] [Google Scholar]
  • Fahie-Wilson, M., Smith, T.P. (2013). Determination of prolactin: The macroprolactin problem. Best Pract Res Clin Endocrinol Metab, 27, 725-742. [CrossRef] [PubMed] [Google Scholar]
  • Ferraris, J., Boutillon, F., Bernadet, M., Seilicovich, A., Goffin, V., Pisera, D. (2012). Prolactin receptor antagonism in mouse anterior pituitary: Effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab, 302, E356-E364. [CrossRef] [PubMed] [Google Scholar]
  • Freeman, M.E., Kanyicska, B., Lerant, A., Nagy, G. (2000). Prolactin: structure, function, and regulation of secretion. Physiol Rev, 80, 1523-1631. [CrossRef] [PubMed] [Google Scholar]
  • Gadd, S.L., Clevenger, C.V. (2006). Ligand-independent dimerization of the human prolactin receptor isoforms: Functional implications. Mol Endocrinol, 20, 2734-2746. [CrossRef] [PubMed] [Google Scholar]
  • Gallego, M. I., Binart, N., Robinson, G.W., Okagaki, R., Coschigano, K.T., Perry, J., Kopchick, J.J., Oka, T., Kelly, P.A., Hennighausen, L. (2001). Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol, 229, 163-175. [CrossRef] [PubMed] [Google Scholar]
  • Gellersen, B., Kempf, R., Telgmann, R., DiMattia, G.E. (1994). Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol, 8, 356-373. [PubMed] [Google Scholar]
  • Grattan, D.R., Jasoni, C.L., Liu, X., Anderson, G.M., Herbison, A.E. (2007). Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocrinology, 148, 4344-4351. [CrossRef] [PubMed] [Google Scholar]
  • Grattan, D.R. (2015). 60 years of neuroendocrinology: The Hypothalamo-prolactin axis. J Endocrinol, 226, T101– T122. [CrossRef] [PubMed] [Google Scholar]
  • Hodson, D.J., Schaeffer, M., Romanò, N., Fontanaud, P., Lafont, C., Birkenstock, J., Molino F., Christian, H., Lockey, J., Carmignac, D., Fernandez-Fuente, M., Le Tissier, P., Mollard, P. (2012). Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nat Commun, 3, 605. [CrossRef] [PubMed] [Google Scholar]
  • Hoskova, K., Bryant, N.K., Chen, M.E., Nachtigall, L.B., Lippincott, M.F., Balasubramanian, R., Seminara, S.B. (2022). Kisspeptin overcomes GnRH neuronal suppression secondary to hyperprolactinemia in humans. J Clin Endocrinol Metab, 107, e3515–e3525. [CrossRef] [PubMed] [Google Scholar]
  • Kelly, M.A., Rubinstein, M., Asa S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Hnasko, R., Ben-Jonathan, N., Grandy, D.K., Low, M.J. (1997). Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron, 19, 103-113. [CrossRef] [PubMed] [Google Scholar]
  • Kobayashi, T., Usui, H., Tanaka, H., Shozu, M. (2018). Variant prolactin receptor in agalactia and hyperprolactinemia. New Engl J Med, 379, 2230-2236. [CrossRef] [PubMed] [Google Scholar]
  • Le Tissier, P., Campos, P., Lafont, C., Romanò, N., Hodson, D.J., Mollard, P. (2017). An updated view of hypothalamic-vascular-pituitary unit function and plasticity. Nat Rev Endocrinol, 13, 257-267. [CrossRef] [PubMed] [Google Scholar]
  • Lecomte, P., Lecomte, C., Lansac, J., Gallier, J., Sonier, C.B., Simonetta C. (1997). Pregnancy after intravenous pulsatile gonadotropin-releasing hormone in a hyperprolactinaemic woman resistant to treatment with dopamine agonists. Eur J Obst Gynecol Reprod Biol, 74, 219-221. [CrossRef] [Google Scholar]
  • Li, Q., Rao, A., Pereira, A., Clarke, I.J., Smith, J.T. (2011). Kisspeptin cells in the ovine arcuate nucleus express prolactin receptor but not melatonin receptor. J Neuroendocrinol, 23, 871-882. [CrossRef] [PubMed] [Google Scholar]
  • Marano, R.J., Ben-Jonathan, N. (2014). Minireview: Extrapituitary prolactin: An update on the distribution, regulation, and functions. Mol Endocrinol, 28, 622-633. [CrossRef] [PubMed] [Google Scholar]
  • Millar, R.P., Sonigo, C., Anderson, R.A., George, J., Maione, L., Brailly-Tabard, S., Chanson, P., Binart, N., Young, J. (2017). Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea. J Endocr Soc, 1, 1362-1371. [CrossRef] [PubMed] [Google Scholar]
  • MohanKumar, P.S., MohanKumar, S.M., Quadri, S.K., Voogt J.L. (2001). Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats. J Neuroendocrinol, 13, 261-269. [CrossRef] [PubMed] [Google Scholar]
  • Morel, G., Ouhtit, A., Kelly P.A. (1994). Prolactin receptor immunoreactivity in rat anterior pituitary. Neuroendocrinology, 59, 78-84. [CrossRef] [PubMed] [Google Scholar]
  • Ormandy, C.J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H., Edery, M., Brousse, N., Babinet, C., Binart, N., Kelly P.A. (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev, 11, 167-178. [CrossRef] [PubMed] [Google Scholar]
  • Peers, B., Voz, M.L., Monget, P., Mathy-Hartert, M., Berwaer, M., Belayew, A., Martial, J.A. (1990). Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol Cell Biol, 10, 4690-4700. [PubMed] [Google Scholar]
  • Postel-Vinay, M.C., Belair, L., Kayser, C., Kelly, P.A., Djiane, J. (1991). Identification of prolactin and growth hormone binding proteins in rabbit milk. Proc Natl Acad Sci USA, 88, 6687-6690. [CrossRef] [PubMed] [Google Scholar]
  • Sauder, S.E., Frager, M., Case, G.D., Kelch, R.P., Marshall, J.C. (1984). Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: Responses to bromocriptine. J Clin Endocrinol Metab, 59, 941-948. [CrossRef] [PubMed] [Google Scholar]
  • Schuff, K.G., Hentges S.T., Kelly, M.A., Binart, N., Kelly, P.A., Iuvone, P.M., Asa, S.L., Low, M.J. (2002). Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest, 11, 973-981. [CrossRef] [PubMed] [Google Scholar]
  • Smith, J.T., Li, Q., Yap, K.S., Shahab, M., Roseweir, A.K., Millar, R.P., Clarke, I.J. (2011). Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology, 152, 1001-1012. [CrossRef] [PubMed] [Google Scholar]
  • Sonigo, C., Bouilly, J., Carré, N., Tolle, V., Caraty, A., Tello, J., Simony-Conesa, F.-J., Millar, R., Young, J., Binart, N. (2012). Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest, 122, 3791-3795. [CrossRef] [PubMed] [Google Scholar]
  • Vilar, L., Freitas, M.C., Naves, L.A., Casulari, L.A, Azevedo, M., Montenegro, R., Barros, A. I., Faria, M., Nascimento, G.C., Lima, J.G., Nóbrega, L.H., Cruz, T.P., Mota, A., Ramos, A., Violante, A., Lamounier Filho, A., Gadelha, M.R., Czepielewski, M.A., Glezer, A., Bronstein, M.D. (2008). Diagnosis and management of hyperprolactinemia: Results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest, 31, 436-444. [Google Scholar]
  • Walker, A.M. (2007). S179D Prolactin: antagonistic agony! Mol Cell Endocrinol, 276, 1-9. [CrossRef] [PubMed] [Google Scholar]
  • Waters, M.J., Brooks, A.J., Chhabra, Y. (2014). A new mechanism for growth hormone receptor activation of Jak2, and implications for related cytokine receptors. JAK-STAT, 3, e29569. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.